role of endocrine therapy in early-stage hr-positive breast cancer
Published 3 weeks ago • 17 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
0:35
duration of endocrine therapy in early breast cancer
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
-
6:09
adjuvant endocrine therapy for breast cancer: optimal durations and regimens
-
8:18
endocrine therapy in premenopausal women with hr breast cancer
-
4:01
advances in the teatment of high-risk early-stage hormone receptor positive breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
1:39
frontline endocrine therapies and ribociclib in early stage hr her2- breast cancer
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
1:00
therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancer
-
8:30
hr breast cancer: endocrine therapy, surgery and radiotherapy
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
1:26
rxponder: chemotherapy and endocrine therapy in hr /her2- breast cancer
-
4:02
assessment of short preoperative endocrine therapy in the adapt and adaptcycle trials
-
1:27
treating er breast cancer patients with endocrine therapy resistance
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer